Khalil Helou

3.0k total citations
114 papers, 2.2k citations indexed

About

Khalil Helou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Khalil Helou has authored 114 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 30 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Khalil Helou's work include Effects of Radiation Exposure (16 papers), Genomic variations and chromosomal abnormalities (16 papers) and Cancer Genomics and Diagnostics (15 papers). Khalil Helou is often cited by papers focused on Effects of Radiation Exposure (16 papers), Genomic variations and chromosomal abnormalities (16 papers) and Cancer Genomics and Diagnostics (15 papers). Khalil Helou collaborates with scholars based in Sweden, United States and Belgium. Khalil Helou's co-authors include Toshima Z. Parris, Per Karlsson, Anikó Kovács, Eva Forssell‐Aronsson, Szilárd Nemes, Nils-Petter Rudqvist, Britta Langen, Shahin Hajizadeh, Zakaria Einbeigi and Emil Schüler and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Khalil Helou

108 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalil Helou Sweden 27 1.2k 514 508 348 296 114 2.2k
David G. Cox United States 28 1.2k 1.0× 634 1.2× 517 1.0× 575 1.7× 248 0.8× 69 2.3k
Stewart G. Martin United Kingdom 31 1.7k 1.3× 817 1.6× 1.1k 2.1× 215 0.6× 404 1.4× 104 3.2k
José Palacios Spain 26 1.5k 1.2× 441 0.9× 870 1.7× 290 0.8× 288 1.0× 58 2.9k
Adayabalam S. Balajee United States 28 2.2k 1.8× 662 1.3× 693 1.4× 270 0.8× 323 1.1× 82 2.9k
Alastair M. Thompson United States 19 1.4k 1.1× 540 1.1× 684 1.3× 285 0.8× 173 0.6× 37 2.8k
Ana M. Tari United States 31 1.7k 1.4× 367 0.7× 708 1.4× 256 0.7× 167 0.6× 65 2.6k
Richard Kendall United States 24 1.8k 1.4× 476 0.9× 837 1.6× 153 0.4× 268 0.9× 43 3.0k
Atanas Ignatov Germany 29 842 0.7× 534 1.0× 670 1.3× 763 2.2× 292 1.0× 133 2.5k
Michele De Bortoli Italy 32 2.0k 1.6× 808 1.6× 1.0k 2.0× 614 1.8× 218 0.7× 97 3.2k
Somaira Nowsheen United States 37 2.1k 1.7× 480 0.9× 1.3k 2.6× 253 0.7× 357 1.2× 74 3.2k

Countries citing papers authored by Khalil Helou

Since Specialization
Citations

This map shows the geographic impact of Khalil Helou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Helou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Helou more than expected).

Fields of papers citing papers by Khalil Helou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Helou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Helou. The network helps show where Khalil Helou may publish in the future.

Co-authorship network of co-authors of Khalil Helou

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Helou. A scholar is included among the top collaborators of Khalil Helou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Helou. Khalil Helou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rönnerman, Elisabeth Werner, Pernilla Dahm‐Kähler, Per Karlsson, et al.. (2025). Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics. PubMed. 33(3). 201019–201019. 1 indexed citations
2.
Garré, Elena, Sara Rhost, Anna Gustafsson, et al.. (2025). Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity. Communications Biology. 8(1). 621–621.
3.
Larsson, Peter, Maria Cristina De Rosa, Benedetta Righino, et al.. (2024). Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties. Scientific Reports. 14(1). 18772–18772. 1 indexed citations
4.
Larsson, Peter, Alexandra Abramsson, Henrik Zetterberg, et al.. (2024). Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. Cell Death Discovery. 10(1). 57–57. 11 indexed citations
5.
Andersson, Charlotte, Amin Al-Awar, Emman Shubbar, et al.. (2023). Co-administration with A1M does not influence apoptotic response of 177Lu-octreotate in GOT1 neuroendocrine tumors. Scientific Reports. 13(1). 6417–6417. 1 indexed citations
6.
Rönnerman, Elisabeth Werner, Szilárd Nemes, Pernilla Dahm‐Kähler, et al.. (2023). Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma. Frontiers in Oncology. 12. 1112152–1112152. 3 indexed citations
7.
Leiva, María C., Elena Garré, Anders Ståhlberg, et al.. (2023). Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features. Journal of Translational Medicine. 21(1). 924–924. 4 indexed citations
8.
Langen, Britta, Egor Vorontsov, Johan Spetz, et al.. (2022). Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment. Scientific Reports. 12(1). 7000–7000. 10 indexed citations
9.
Engqvist, Hanna, Toshima Z. Parris, Jana Biermann, et al.. (2020). Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes. Scientific Reports. 10(1). 7946–7946. 16 indexed citations
10.
Langen, Britta, Khalil Helou, & Eva Forssell‐Aronsson. (2020). The IRI-DICE hypothesis: ionizing radiation-induced DSBs may have a functional role for non-deterministic responses at low doses. Radiation and Environmental Biophysics. 59(3). 349–355. 3 indexed citations
11.
Hultborn, Ragnar, et al.. (2020). Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report. Case Reports in Oncology. 13(2). 956–961.
12.
Masoumi, Katarzyna Chmielarska, et al.. (2014). Association of Nuclear-Localized Nemo-Like Kinase with Heat-Shock Protein 27 Inhibits Apoptosis in Human Breast Cancer Cells. PLoS ONE. 9(5). e96506–e96506. 19 indexed citations
13.
Parris, Toshima Z., Anikó Kovács, Shahin Hajizadeh, et al.. (2014). Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer. 14(1). 324–324. 35 indexed citations
14.
Parris, Toshima Z., Anna Danielsson, Szilárd Nemes, et al.. (2010). Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma. Clinical Cancer Research. 16(15). 3860–3874. 82 indexed citations
15.
Nilsson, Jeanette, Khalil Helou, Anikó Kovács, et al.. (2010). Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1. Cancer Research. 70(5). 2020–2029. 58 indexed citations
16.
Kovács, Anikó, Kristina Lövgren, Szilárd Nemes, et al.. (2010). Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray. BMC Cancer. 10(1). 296–296. 30 indexed citations
17.
Adamović, Tatjana, et al.. (2008). Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer. Cancer Genetics and Cytogenetics. 184(1). 9–21. 6 indexed citations
18.
Qiu, Yan, et al.. (2004). Regional Mapping of the Mlvi2 Locus to Rat Chromosome 2q16 by FISH. Hereditas. 127(3). 263–264.
19.
Liška, František, G. Levan, Khalil Helou, et al.. (2002). Chromosome Assignment of Cd36 Transgenes in Two Rat SHR Lines by FISH and Linkage Mapping of Transgenic Insert in the SHR-TG19 Line. Folia Biologica. 48(4). 139–144. 2 indexed citations
20.
Helou, Khalil, Anna Walentinsson, Åsa Johansson, et al.. (2001). Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization. Cancer Genetics and Cytogenetics. 127(2). 118–127. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David G. Cox Breakdown of academic impact, for papers by Stewart G. Martin Breakdown of academic impact, for papers by José Palacios Breakdown of academic impact, for papers by Adayabalam S. Balajee Breakdown of academic impact, for papers by Alastair M. Thompson Breakdown of academic impact, for papers by Ana M. Tari Breakdown of academic impact, for papers by Richard Kendall Breakdown of academic impact, for papers by Atanas Ignatov Breakdown of academic impact, for papers by Michele De Bortoli Breakdown of academic impact, for papers by Somaira Nowsheen
Rankless by CCL
2026